BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 21054711)

  • 1. Therapeutic hotline: Primary cutaneous CD4 + small/medium-sized pleomorphic T cell lymphoma coexisting with myelodysplastic syndrome transforming into chronic myelomonocytic leukemia successfully treated with cyclophosphamide.
    Wawrzycki B; Chodorowska G; Pietrzak A; Jazienicka I; Skomra D; Kowal M; Dybiec E; Hercogova J
    Dermatol Ther; 2010; 23(6):676-81. PubMed ID: 21054711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphomas: a practical marriage of two giants.
    Slater DN
    Br J Dermatol; 2005 Nov; 153(5):874-80. PubMed ID: 16225594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The applicability of the new WHO-EORTC classification of primary cutaneous lymphomas to a single referral center.
    Khamaysi Z; Ben-Arieh Y; Izhak OB; Epelbaum R; Dann EJ; Bergman R
    Am J Dermatopathol; 2008 Feb; 30(1):37-44. PubMed ID: 18212543
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An unusual cutaneous T cell lymphoma presenting as leonine facies.
    Vocks E; Hertenberger B; Worret WI; Kaudewitz P; Fellbaum C; Ring J
    Eur J Dermatol; 2000 Jun; 10(4):309-12. PubMed ID: 10846262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of programmed death-1 in primary cutaneous CD4-positive small/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma.
    Cetinözman F; Jansen PM; Willemze R
    Am J Surg Pathol; 2012 Jan; 36(1):109-16. PubMed ID: 21989349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
    Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
    J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous CD4+ small- to medium-sized pleomorphic T-cell lymphoma: temporary remission by oral doxycycline.
    Toberer F; Hartschuh W; Hadaschik E
    JAMA Dermatol; 2013 Aug; 149(8):956-9. PubMed ID: 23760549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary cutaneous T-cell lymphoma expressing FOXP3: a case report supporting the existence of malignancies of regulatory T cells.
    Marzano AV; Vezzoli P; Fanoni D; Venegoni L; Berti E
    J Am Acad Dermatol; 2009 Aug; 61(2):348-55. PubMed ID: 19615546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-mycosis fungoides cutaneous T-cell lymphoma: reclassification according to the WHO-EORTC classification.
    Weaver J; Mahindra AK; Pohlman B; Jin T; Hsi ED
    J Cutan Pathol; 2010 May; 37(5):516-24. PubMed ID: 20132421
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
    Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
    J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleomorphic CD8+ small/medium size cutaneous T-cell lymphoma.
    Khamaysi Z; Ben-Arieh Y; Epelbaum R; Bergman R
    Am J Dermatopathol; 2006 Oct; 28(5):434-7. PubMed ID: 17012921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of modulation of CD4+CD25 regulatory T cells in CTCL patients treated with bexarotene.
    Knol AC; Quéreux G; Brocard A; Ballanger F; Khammari A; Nguyen JM; Dréno B
    Exp Dermatol; 2010 Aug; 19(8):e95-102. PubMed ID: 19845755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of T(H)2 cytokine messenger RNA expression in CD30-negative primary cutaneous large T-cell lymphomas.
    Vermeer MH; Tensen CP; van der Stoop PM; van Oostveen HW; Lund M; Scheper RJ; Willemze R
    Arch Dermatol; 2001 Jul; 137(7):901-5. PubMed ID: 11453809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cutaneous CD4+ small-/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases.
    Beltraminelli H; Leinweber B; Kerl H; Cerroni L
    Am J Dermatopathol; 2009 Jun; 31(4):317-22. PubMed ID: 19461234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathologic, immunophenotypic, and molecular study of 22 Asian cases according to WHO-EORTC classification.
    Kong YY; Dai B; Kong JC; Zhou XY; Lu HF; Shen L; Du X; Shi DR
    Am J Surg Pathol; 2008 Oct; 32(10):1495-502. PubMed ID: 18708940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leukaemic cutaneous T-cell lymphoma-manifesting papuloerythroderma with CD3(-) CD4(+) phenotype.
    Shimauchi T; Sugita K; Nakamura M; Tokura Y
    Acta Derm Venereol; 2010; 90(1):68-72. PubMed ID: 20107729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary cutaneous CD4+ small to medium-size pleomorphic T-cell lymphoma in a 12-year-old girl.
    Volks N; Oschlies I; Cario G; Weichenthal M; Fölster-Holst R
    Pediatr Dermatol; 2013; 30(5):595-9. PubMed ID: 23756295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary cutaneous blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation: case report and review of the literature.
    Li Y; Li Z; Lin HL; Chen XH; Li B
    Pathol Res Pract; 2011 Jan; 207(1):55-9. PubMed ID: 20573459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop.
    Santucci M; Pimpinelli N; Massi D; Kadin ME; Meijer CJ; Müller-Hermelink HK; Paulli M; Wechsler J; Willemze R; Audring H; Bernengo MG; Cerroni L; Chimenti S; Chott A; Díaz-Pérez JL; Dippel E; Duncan LM; Feller AC; Geerts ML; Hallermann C; Kempf W; Russell-Jones R; Sander C; Berti E;
    Cancer; 2003 Feb; 97(3):610-27. PubMed ID: 12548603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.